Apogee Therapeutics: Funding, Investors & Team (Sep 2026)
Apogee Therapeutics, a biotechnology company headquartered in San Francisco, California, was established in 2022 with a focus on developing innovative therapies for immunological and inflammatory conditions to meet the needs of patients.
Apogee Therapeutics has raised $2.0B across 3 funding rounds on record, the most recent an undisclosed round of $1.3B announced in May 2026.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Apogee Therapeutics Company Profile and Key Stats
Latest funding round on record: May 2026.
Apogee Therapeutics Funding Rounds
Apogee Therapeutics raised $345M in an undisclosed round announced in Oct 2025.
5 months later, an undisclosed round of $350M was announced in Mar 2026.
2 months later, an undisclosed round of $1.3B was announced in May 2026.
Apogee Therapeutics Founders and Leadership Team
Contact details for the Apogee Therapeutics team: 1 of 2 have an email address on file, 1 has a LinkedIn profile.
Start 14-day free trial →Apogee Therapeutics Funding Compared to Other Biotechnology Startups
Apogee Therapeutics' latest round of $1.3B is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Apogee Therapeutics in Biotechnology and San Francisco
Companies Similar to Apogee Therapeutics
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Paterna BioSciences, Inc. is a pioneering biotechnology company dedicated to solving the significant…
Legendary Bio's solidarity is a determined spotlight on introducing another period of quality guideline.
Cataract surgery is the single most common procedure performed in the United States annually. Despite…
InSitu Biologics is a developer of a drug delivery platform designed to focus on development of new and…
Remedium Bio is a gene therapy company in the Boston area that is dedicated to developing cures for severe…
Apogee Therapeutics Funding FAQs
What does Apogee Therapeutics do?
Apogee Therapeutics, a biotechnology company headquartered in San Francisco, California, was established in 2022 with a focus on developing innovative therapies for immunological and inflammatory conditions to meet the needs of patients.
How much funding has Apogee Therapeutics raised?
Apogee Therapeutics has raised $2.0B across 3 rounds on record. The most recent is an undisclosed round of $1.3B announced in May 2026.
When did Apogee Therapeutics last raise funding?
Apogee Therapeutics' most recent funding round on record is an undisclosed round of $1.3B, announced in May 2026.
Who founded Apogee Therapeutics?
FundedIQ lists Michael Henderson (Founder), Nimish Shah (Founder) at Apogee Therapeutics.
Where is Apogee Therapeutics headquartered?
Apogee Therapeutics is based in San Francisco, California, United States.
How many employees does Apogee Therapeutics have?
Apogee Therapeutics is in the 251-500 employee band.
How does Apogee Therapeutics' funding compare to other Biotechnology startups?
Apogee Therapeutics' latest round of $1.3B is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's Apogee Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Apogee Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.